Discovery and development of insulin lispro

Drugs of Today

Volumn 34, Issue SUPPL. C, 1998, Pages 1-9

  Chance, Ronald E ^a   Frank, Bruce H ^a   Radziuk, Jerry M ^b   DiMarchi, Richard D ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN LISPRO; PROINSULIN; RECOMBINANT DNA; SOMATOMEDIN B; SOMATOMEDIN C; ZINC;

AMINO ACID SEQUENCE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG FORMULATION; HUMAN; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031810210     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Banting, F.G., Best, C.H., Macleod, J.J.R. The internal secretion of the pancreas. Am J Physiol 1922, 59: 479.
2. Banting, F.G., Best, C.H. The internal secretion of the pancreas. J Lab Clin Med 1922, 7: 251-66.
3. Bliss, M. The Discovery of Insulin. 75th Anniversary Edition. McClelland & Stewart Inc.: Toronto 1996, 11.
4. Chance, R.E., Frank, B.H. Research, development, production, and safety of biosynthetic human insulin. Diabetes Care 1993, 16 (Suppl. 3): 133-42.
5. Ross, P.E. Better than mother nature. Forbes 1996, 150-4.
6. Steiner, D.F. Insulin today. The Banting Memorial Lecture 1976. Diabetes 1977, 26: 322-40.
7. Brange, J. (Ed.). Galenics of Insulin. The Physico-chemical and Pharmaceutical Aspects of Insulin and Insulin Preparations. Springer-Verlag: Berlin 1987, 17.
8. Galloway, J.A., Chance, R.E. Improving insulin therapy: Achievements and challenges. Horm Metab Res 1994, 26: 591-8.
9. Hua, Q.-X., Gozani S.N., Chance, R.E., Hoffmann, J.A., Frank, B.H., Weiss, M.A. Structure of a protein in a kinetic trap. Nat Struct Biol 1995, 2: 129-38.
10. Hua, Q.-X., Hu, S.-Q., Frank, B.H. et al. Mapping the functional surface of insulin by design: Structure and function of a novel A-chain analogue. J Mol Biol 1996, 264: 390-403.
11. Jørgensen, A.M.M., Olsen, H.B., Balschmidt, P., Led, J.J. Solution structure of the superactive monomeric des[phe(B25)] human insulin mutant: Elucidation of the structural basis for the monomerization of des-[phe(B25)] insulin and the dimerization of native insulin. J Mol Biol 1996, 257: 684-99.
12. Llewelyn, J., Slieker, L.J., Zimmermann, J.L. Preclinical studies on insulin lispro. Drugs Today 1998, 34 (Suppl. C): 11-21.
13. Heinemann, L., Woodworth, J.R. Pharmacokinetics and glucodynamics of insulin lispro. Drugs Today 1998, 34 (Suppl. C): 23-36.
14. Anderson, J.H. Jr., Koivisto, V.A. Clinical Studies on insulin lispro. Drugs Today 1998, 34 (Suppl. C): 37-50.
15. Frank, B.H., Pettee, J.M., Zimmerman, R.E., Burck, P.J. The production of human proinsulin and its transformation to human insulin and C-peptide. In: Peptides: Synthesis-Structure-Function Proceedings of the Seventh American Peptide Symposium. Rich, D.H., Gross, E. (Eds.). Pierce Chemical Co.: Rockford 1981, 729-38.
16. Galloway, J.A., Hooper, S.A., Spradlin, C.T. et al. Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 1992, 15: 666-92.
17. DiMarchi, R., Long, H., Epp, J., Schoner, B., Belagaje, R. Synthesis of insulin-like growth factor I through recombinant DNA techniques and selective chemical cleavage at tryptophan. In: Synthetic Peptides: Approaches to Biological Problems. Tam, J.P., Kaiser, E.T. (Eds.). Alan R. Liss: New York 1989, 283-94.
18. Furman, T.C., Epp, J., Hsiung, H.M. et al. Recombinant human insulin-like growth factor II expressed in Escherichia coli. Biotechnology 1987, 5: 1047-51.
19. Chance, R.E., Hoffmann, J.A., Kroeff, E.P. et al. The production of human insulin using recombinant DNA technology and a new chain combination procedure. In: Peptides: Synthesis-Structure-Function. Proceedings of the Seventh American Peptide Symposium. Rich, D.H., Gross, E. (Eds.). Pierce Chemical Co.: Rockford 1981, 721-8.
20. Brange, J., Owens, D.R., Kang, S., Vølund, A. Monomeric insulins and their experimental and clinical implications. Diabetes Care 1990, 13: 923-54.
21. DiMarchi, R.D., Mayer, J.P., Fan, L. et al. Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In: Peptides. Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium. Smith, J.A., Rivier, J.E. (Eds.). ESCOM: Leiden 1992, 26-8.
22. Markussen, J., Hougaard, P., Ribel, U., Sørensen, A.R., Sorensen, E. Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain. Protein Eng 1987, 1: 205-13.
23. Markussen, J., Diers, J., Engesgaard, A. et al. Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30. Protein Eng 1987, 1: 215-23.
24. B32]insulin (HOE 901) in muscle cells. Eur J Pharmacol 1997, 320: 259-65.
25. JDFI World Conference on Diabetes Research. Current Status, Future Directions. Report of the Juvenile Diabetes Foundation International World Conference on Diabetes Research (Nov 2-6, Monaco) 1985, 42.
26. Blundell, T., Dodson, G., Hodgkin, D., Mercola, D. Insulin: The structure in the crystal and its reflection in chemistry and biology. Adv Protein Chem 1972, 26: 279-402.
27. Baker, E.N., Blundell, T.L., Cutfield, J.F. et al. The structure of 2Zn pig insulin crystals at 1.5 Å resolution. Proc R Soc Lond B Biol Sci 1988, 319: 369-456.
28. Mosekilde, E., Jensen, K.S., Binder, C., Pramming, S., Thorsteinsson, B. Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm 1989, 17: 67-87.
29. Emdin, S.O., Dodson, G.G., Cutfield, J.M., Cutfield, S.M. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic β-cell. Diabetologia 1980, 19: 174-82.
30. Pekar, A.H., Frank, B.H. Conformation of proinsulin. A comparison of insulin and proinsulin self-association at neutral pH. Biochemistry 1972, 11: 4013-6.
31. Hvidt. S. Insulin association in neutral solutions studied by light scattering. Biophys Chem 1991, 39: 205-13.
32. Brems, D.N., Alter, L.A., Beckage, M.J. et al. Altering the association properties of insulin by amino acid replacement. Protein Eng 1992, 5: 527-33.
33. DiMarchi, R.D., Chance, R.E., Long, H.B., Shields, J.E., Slieker, L.J. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 1994, 41 (Suppl. 2): 93-6.
34. Long, H.B., Baker, J.C., Belagaje, R.M. et al. Human insulin analogs with rapid onset and short duration of action. In: Peptides. Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium. Smith, J.A., Rivier, J.E. (Eds.). ESCOM: Leiden 1992, 88-90.
35. Frank, B.H., Brems, D.N., Chance, R.E., DiMarchi, R.D., Shields, J.E. Manipulation of the position of proline in the B-chain produces monomeric insulins. Diabetes 1991, 40 (Suppl. 1): 423A.
36. Chance, R.E., DiMarchi, R.D., Frank, B.H., Shields, J.E. Insulin analogs modified at position 29 of the B chain. US Patent Number 5514646, 1996.
37. Slieker, L.J., Brooke, G.S., DiMarchi, R.D. et al. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 1997, 40 (Suppl. 2): S54-61.
38. Shaw, W.N., Su, K.S.E. Biological aspects of a new human insulin analog: [Lys(B28), Pro(B29)]-human insulin. Diabetes 1991, 40 (Suppl. 1): 464A.
39. Galloway, J.A., Chance, R.E., Su, K.S.E. Human insulin and its modifications. In: The Clinical Pharmacology of Biotechnology Products. Reidenberg, M.M. (Ed.). Elsevier: Amsterdam 1991, 23-34.
40. Su, K.S., Campanale, K.M., Chance, R.E., Hoffmann, J.A. Using dog model for comparing time action of insulins af ter subcutaneous (s.c.) injection: Prediction of rapid onset of a new insulin analog [Lys(B28).Pro(B29)]-human insulin (KP). Pharm Res 1994, 11 (Suppl.): S-357.
41. B29-insulin: Dissociation of a protein-ligand complex. Protein Sci 1996, 5: 2521-31.
42. B29-human insulin - assessed in a conscious pig model. Diabetes 1997, 46: 548-56.
43. B29-human insulin. Structure 1995, 3: 615-22.
44. B29-insulin hexamers: A comparison study. Pharm Res 1997, 14: 25-36.
45. B29-human insulin (insulin lispro): Solution properties of a rapid-acting insulin. Diabetologia 1995, 38 (Suppl. 1): A189.
46. Anderson, J.H. Jr., Wilke, T.S., DiMarchi, R.D., Chance, R.E. Insulin analogues: Designer insulins with improved characteristics for better patient care. Diabetes News 1996, XVII(2): 5-7.